An electrochemical SARS-CoV-2 biosensor inspired by glucose test strip manufacturing processes.


Journal

Chemical communications (Cambridge, England)
ISSN: 1364-548X
Titre abrégé: Chem Commun (Camb)
Pays: England
ID NLM: 9610838

Informations de publication

Date de publication:
18 Apr 2021
Historique:
pubmed: 18 3 2021
medline: 22 4 2021
entrez: 17 3 2021
Statut: ppublish

Résumé

Accurate and rapid diagnostic tests are critical to reducing the impact of SARS-CoV-2. This study presents early, but promising measurements of SARS-CoV-2 using the ACE2 enzyme as the recognition element to achieve clinically relevant detection. The test provides a scalable route to sensitive, specific, rapid and low cost mass testing.

Identifiants

pubmed: 33729260
doi: 10.1039/d1cc00936b
doi:

Substances chimiques

Enzymes, Immobilized 0
Fluorocarbons 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0
Gold 7440-57-5
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3704-3707

Subventions

Organisme : Chief Scientist Office
ID : COV/SCL/20/04
Pays : United Kingdom

Auteurs

Vincent J Vezza (VJ)

Biomedical Engineering, University of Strathclyde, Glasgow, G1 1XP, UK. vincent.vezza@strath.ac.uk.

Adrian Butterworth (A)

Biomedical Engineering, University of Strathclyde, Glasgow, G1 1XP, UK. vincent.vezza@strath.ac.uk.

Perrine Lasserre (P)

Biomedical Engineering, University of Strathclyde, Glasgow, G1 1XP, UK. vincent.vezza@strath.ac.uk.

Ewen O Blair (EO)

Biomedical Engineering, University of Strathclyde, Glasgow, G1 1XP, UK. vincent.vezza@strath.ac.uk.

Alexander MacDonald (A)

Biomedical Engineering, University of Strathclyde, Glasgow, G1 1XP, UK. vincent.vezza@strath.ac.uk.

Stuart Hannah (S)

Biomedical Engineering, University of Strathclyde, Glasgow, G1 1XP, UK. vincent.vezza@strath.ac.uk.

Christopher Rinaldi (C)

Pure & Applied Chemistry, University of Strathclyde, Glasgow, G1 1XP, UK.

Paul A Hoskisson (PA)

Strathclyde Institute of Pharmacy and biomedical Sciences (SIPBS), University of Strathclyde, Glasgow, G1 1XP, UK.

Andrew C Ward (AC)

Civil & Environmental Engineering, University of Strathclyde, Glasgow, G1 1XP, UK.

Alistair Longmuir (A)

LifeScan Scotland Ltd, Beechwood Park North, Inverness, IV2 3ED, UK.

Steven Setford (S)

LifeScan Scotland Ltd, Beechwood Park North, Inverness, IV2 3ED, UK.

Eoghan C W Farmer (ECW)

NHS GGC, Glasgow Royal Infirmary, Department of Microbiology, NEW Lister Building, Glasgow, G31 2ER, UK.

Michael E Murphy (ME)

NHS GGC, Glasgow Royal Infirmary, Department of Microbiology, NEW Lister Building, Glasgow, G31 2ER, UK and School of Medicine, Dentistry & Nursing, College of Medical Veterinary & Life Sciences, University of Glasgow, G12 8QQ, UK.

Damion K Corrigan (DK)

Biomedical Engineering, University of Strathclyde, Glasgow, G1 1XP, UK. vincent.vezza@strath.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH